The easiest solution
In large randomized trials of FDA-approved branded semaglutide, once-weekly treatment alongside lifestyle intervention produced substantial average weight loss over 68 weeks (Wilding et al., 2021), with continued treatment supporting weight maintenance (Rubino et al., 2021)
Razor-sharp mental focus that lasts all day
In clinical weight loss studies, tirzepatide has generally produced greater average weight loss than semaglutide at studied therapeutic doses
Safe & Controlled : When performed correctly, it minimizes risks compared to invasive procedures
In the same review, findings from a cross-sectional study with 1,575 cognitively healthy participants of the Framingham Study showed that individuals in the highest quartile of red blood cell DHA had significantly larger total brain volumes compared with those in the lowest quartile, independent of APOE genotype, homocysteine levels, and other vascular risk factor